- Mike Chace-Ortiz
Senior Director, Thomson Pharma Custom Solutions, Thomson Scientific
- Generic pharmaceuticals: industry, business models, strategy, organization, business development, licensing, R&D, legal and regulatory environment
- Active Pharmaceutical Ingredients (APIs): industry, manufacturers, business strategies
- Pharmaceutical Information systems
- Innovator discovery, research, pre-clinical and clinical development, regulatory and commercial processes: strategy, project management, process improvement, re-engineering, information strategy
Click here to contact
- Peter Robins
Editorial and Content Manager, Drug Information, Pharma/Chem markets, Thomson Scientific
- Drug Information Editorial content and policy
(ie, IDdb and SDdb but also including to some extent Thomson Pharma Drug Content, ie MICROMEDEX, Newport Strategies)
- The drug R&D process from lead identification to launch
- The pharmaceutical industry in general, including strategy and key drivers
- Biotechnology, including biogenerics, and its impact on the pharmaceutical business model
- Emerging technologies such as pharmacogenomics
- Therapeutic taxonomies (ie, diseases and mechanisms of action)
Click here to contact
Back to main Experts page
|
|
